Weiwei Yuan

940 total citations
41 papers, 708 citations indexed

About

Weiwei Yuan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Weiwei Yuan has authored 41 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Weiwei Yuan's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Weiwei Yuan is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Weiwei Yuan collaborates with scholars based in China, United States and Saudi Arabia. Weiwei Yuan's co-authors include Chunyou Wang, Zhiyong Yang, Heshui Wu, Li Li, Shiyong Wu, Liming Dong, Yushun Zhang, Lijuan Chen, Yide Hu and Yu Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Weiwei Yuan

39 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Yuan China 16 383 190 111 108 86 41 708
Qian Nie China 15 377 1.0× 118 0.6× 82 0.7× 62 0.6× 38 0.4× 62 616
Jianan Wang China 19 600 1.6× 272 1.4× 117 1.1× 52 0.5× 61 0.7× 55 926
Xin Gu China 16 372 1.0× 96 0.5× 111 1.0× 83 0.8× 99 1.2× 39 698
Jiongyu Hu China 18 390 1.0× 116 0.6× 111 1.0× 92 0.9× 60 0.7× 44 925
Kevin B. Atkins United States 17 439 1.1× 62 0.3× 89 0.8× 55 0.5× 41 0.5× 23 890
Yao Wu China 17 372 1.0× 138 0.7× 252 2.3× 80 0.7× 123 1.4× 70 814
Katayoon B. Ebrahimi United States 18 679 1.8× 68 0.4× 188 1.7× 56 0.5× 64 0.7× 29 1.4k
Mahmoud Al‐Azab China 12 273 0.7× 80 0.4× 107 1.0× 82 0.8× 62 0.7× 29 566
Yu Peng China 19 519 1.4× 242 1.3× 87 0.8× 119 1.1× 102 1.2× 50 962

Countries citing papers authored by Weiwei Yuan

Since Specialization
Citations

This map shows the geographic impact of Weiwei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yuan more than expected).

Fields of papers citing papers by Weiwei Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yuan. The network helps show where Weiwei Yuan may publish in the future.

Co-authorship network of co-authors of Weiwei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Yuan. A scholar is included among the top collaborators of Weiwei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Yuan. Weiwei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Yuan, Weiwei, Yuhan Zhao, Xueyi Liang, et al.. (2024). BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 275–275. 2 indexed citations
5.
Yuan, Weiwei, Deng Mao, K. J. Zhu, et al.. (2024). The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects. Journal of Translational Medicine. 22(1). 1142–1142. 14 indexed citations
6.
Yuan, Weiwei, Shanshan Hou, Huahua Li, et al.. (2022). The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis. Frontiers in Pharmacology. 13. 918588–918588. 15 indexed citations
7.
Yuan, Weiwei, Hui Sun, & Yu Li. (2020). Long non-coding RNA LINC01116 accelerates the progression of keloid formation by regulating miR-203/SMAD5 axis. Burns. 47(3). 665–675. 17 indexed citations
8.
Chu, Minjie, Shuangshuang Wu, Wei Wang, et al.. (2019). Functional variant of the carboxypeptidase M (CPM) gene may affect silica-related pneumoconiosis susceptibility by its expression: a multistage case–control study. Occupational and Environmental Medicine. 76(3). 169–174. 14 indexed citations
9.
Yuan, Weiwei, Wei Xu, Yan Li, et al.. (2019). TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription. Cell Death and Disease. 10(4). 283–283. 16 indexed citations
10.
Chen, Bo, et al.. (2019). Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer. Journal of Cancer. 10(23). 5793–5804. 20 indexed citations
11.
Wu, Shuangshuang, Liping Mao, Yan Li, et al.. (2018). RAGE may act as a tumour suppressor to regulate lung cancer development. Gene. 651. 86–93. 13 indexed citations
12.
Xu, Wei, Yue Li, Yuan Yin, et al.. (2017). TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma. Oncology Reports. 38(3). 1815–1821. 14 indexed citations
13.
Liu, Wenying, Yu Xiao, Minghui Zhang, et al.. (2015). PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer. PLoS ONE. 10(8). e0128943–e0128943. 36 indexed citations
14.
Yuan, Weiwei, Jie-Ning Zhu, Qiu‐Xiong Lin, et al.. (2015). Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes. Metabolism. 64(12). 1682–1693. 13 indexed citations
15.
Yuan, Weiwei, Chunmei Tang, Jie-Ning Zhu, et al.. (2015). CDK6 mediates the effect of attenuation of miR-1 on provoking cardiomyocyte hypertrophy. Molecular and Cellular Biochemistry. 412(1-2). 289–296. 32 indexed citations
16.
Zhou, Yi, et al.. (2014). Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis. Journal of Cancer Research and Therapeutics. 10(7). 225–225. 12 indexed citations
17.
Lin, Qiu‐Xiong, Jie-Ning Zhu, Xiaohong Li, et al.. (2014). The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart. Molecular and Cellular Biochemistry. 397(1-2). 7–16. 19 indexed citations
18.
Yuan, Weiwei, Zhang Xue-lin, Yu Xu, et al.. (2012). Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma. Molecular Carcinogenesis. 53(1). 49–57. 34 indexed citations
19.
Yu, Lili, et al.. (2010). In Silicon Cloning and Analysis of a LACS Gene from Glycine Max (L.). International Journal of Biology. 2(1). 2 indexed citations
20.
Yan, Ling, Zhiyong Yang, Tao Yin, et al.. (2010). Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro. International Immunopharmacology. 11(2). 187–193. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Nie Breakdown of academic impact, for papers by Jianan Wang Breakdown of academic impact, for papers by Xin Gu Breakdown of academic impact, for papers by Jiongyu Hu Breakdown of academic impact, for papers by Kevin B. Atkins Breakdown of academic impact, for papers by Yao Wu Breakdown of academic impact, for papers by Katayoon B. Ebrahimi Breakdown of academic impact, for papers by Mahmoud Al‐Azab Breakdown of academic impact, for papers by Yu Peng
Rankless by CCL
2026